What motivates us? Hearing about our clients’ positive results! “Inovio Pharmaceuticals Demonstrates PSA Stabilizing Effect of INO-5150 Immunotherapy in Phase 1b Study for Prostate Cancer”.
Read more at the Inovio website.
What motivates us? Hearing about our clients’ positive results! “Inovio Pharmaceuticals Demonstrates PSA Stabilizing Effect of INO-5150 Immunotherapy in Phase 1b Study for Prostate Cancer”.
Read more at the Inovio website.
DFnet is a healthcare technology company that provides eClinical solutions, including electronic data capture, eSource, and data management services. We bring more flexibility, better data quality, and greater efficiency to clinical trials everywhere in the world.
2023 © DF/Net Research, Inc. All Rights Reserved
This website automatically uses the cookies needed to optimize your navigation. To allow additional cookies used to personalize content relevant to you, click “YES, I ACCEPT.”